Avantor (AVTR) revenue breakdown
By segment, Laboratory Solutions is the largest at 67% of fiscal 2025 revenue; Bioscience Production grew fastest, 24% a year over 8 years.
By product, Proprietary is the largest at 53% of fiscal 2025 revenue, growing 11% a year over 7 years.
Revenue by segment
Fiscal years, as Avantor reports them in its 10-K filings; fiscal 2025 total $6.6B.
| Segments | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Laboratory Solutions | — | — | — | — | — | $5.0B | $4.7B | $4.6B | $4.4B | 67% |
| Bioscience Production | $381M | $2.1B | $2.1B | $2.3B | $2.7B | $2.5B | $2.2B | $2.2B | $2.2B | 33% |
| Americas | $688M | $3.5B | $3.6B | $3.7B | $4.2B | — | — | — | — | — |
| AMEA | $178M | $308M | $354M | $375M | $471M | — | — | — | — | — |
Revenue by product
Fiscal years, as Avantor reports them in its 10-K filings; fiscal 2025 total $6.6B.
| Products | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|
| Proprietary | $1.7B | $1.8B | $2.0B | $2.5B | $4.0B | $3.7B | $3.6B | $3.4B | 53% |
| Third-party | $2.6B | $2.6B | $2.7B | $2.9B | $3.5B | $3.2B | $3.2B | $3.1B | 47% |
| Equipment & instrumentation | $909M | $912M | $861M | $1.0B | — | — | — | — | — |
| Services & specialty procurement | $696M | $779M | $818M | $923M | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for AVTR.
Open AVTR in InvestinglyQuestions
Where does Avantor make its money?
In fiscal 2025, by segment: Laboratory Solutions $4.4B, Bioscience Production $2.2B.
From Avantor's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.